- Global Pharma News & Resources

Global Human Vaccine Market Report 2018-2022: Innovative Partnerships Improving Global Vaccine Access -

The "Global Human Vaccine Market 2018-2022" report has been added to's offering.

The Global Human Vaccine Market to grow at a CAGR of 7.73% during the period 2018-2022.

Global Human Vaccines Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also includes a discussion of the Key vendors operating in this market. To calculate the market size, the report considers the revenue generated from the retail sales of human vaccines across the globe. Vaccines have been impacting the global health scenario by reducing disease incidence, mortality rates, and life expectancy.

According to the report, one driver influencing this market is the increase in investments in vaccine segment. High investments by vaccine manufacturers are necessary to develop a wide variety of vaccines, reduce product and process complexity, and maintain aggressive timelines for vaccine development and life cycle management.

One trend affecting this market is the varied demand for vaccines in high-income and developing countries. The demand for novel vaccines is high in developing economies as they receive financial support.

Further, the report states that one challenge affecting this market is the rising pricing pressure. Leading companies have been under pressure from medical associations to lower the price of vaccines so that governments can procure them for public immunization programs.

Key Market Trends

  • Varied demand for vaccines in high-income and developing countries
  • Increase in strategic alliances and M&A
  • Public-private partnership models and technology transfer to local players
  • Innovative partnerships improving global vaccine access
  • Emergence of new technologies for delivery of vaccines
  • Differential pricing to accelerate uptake in low-income countries

Key vendors

  • GlaxoSmithKline
  • Merck
  • Pfizer
  • Sanofi

For more information about this report visit

View source version on

Editor Details

Last Updated: 25-Oct-2018